Procaps Group S.A. (NASDAQ:PROC) Sees Large Decrease in Short Interest

Procaps Group S.A. (NASDAQ:PROC) was the recipient of a significant decline in short interest in December. As of December 15th, there was short interest totalling 163,300 shares, a decline of 21.7% from the November 30th total of 208,500 shares. Based on an average trading volume of 96,000 shares, the short-interest ratio is currently 1.7 days. Currently, 0.2% of the company’s shares are sold short.

Procaps Group Stock Performance

Shares of NASDAQ PROC opened at $2.28 on Tuesday. The stock has a 50 day moving average price of $1.82 and a 200 day moving average price of $2.06. The firm has a market capitalization of $257.23 million, a price-to-earnings ratio of 4.38 and a beta of 0.10. Procaps Group has a 52-week low of $0.50 and a 52-week high of $4.95.

About Procaps Group

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.